Pluristem Therapeutics Reaches New 52-Week Low at $2.89 (PSTI)
Pluristem Therapeutics (NASDAQ:PSTI)’s share price reached a new 52-week low during mid-day trading on Tuesday , Analyst RN reports. The stock traded as low as $2.89 and last traded at $2.91, with a volume of 183,942 shares trading hands. The stock had previously closed at $3.02.
The stock has a 50-day moving average of $3.27 and a 200-day moving average of $3.68. The company’s market cap is $196.9 million.
Pluristem Therapeutics (NASDAQ:PSTI) last posted its quarterly earnings results on Thursday, May 22nd. The company reported ($0.14) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.14). On average, analysts predict that Pluristem Therapeutics will post $-0.60 earnings per share for the current fiscal year.
Pluristem Therapeutics Inc (NASDAQ:PSTI) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.